ME Therapeutics Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 9, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020
Market Capitalization	121	69	-	-	-	-
Enterprise Value	120	68	-	-	-	-
Last Close Price	4.10	2.75	-	-	-	-
PB Ratio	65.88	46.94	-	-	-	-
P/TBV Ratio	65.88	46.94	-	-	-	-
Debt / Equity Ratio	0.05	-	0.08	-1.46	-3.40	1.65
Quick Ratio	12.01	24.05	4.41	0.57	2.27	12.09
Current Ratio	12.23	24.45	4.52	0.59	2.27	12.09
Return on Equity (ROE)	-67.33%	-129.52%	-3327.53%	-	-2126.14%	-
Return on Assets (ROA)	-40.68%	-77.65%	-157.78%	-106.78%	-60.78%	-
Return on Capital (ROIC)	-42.21%	-84.18%	-195.65%	-183.72%	-82.93%	-
Earnings Yield	-0.96%	-1.87%	-	-	-	-
Buyback Yield / Dilution	-21.58%	-55.90%	-84.08%	-39.53%	-0.07%	-

Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.